One of i~HD’s founding members, Mats Sundgren from AstraZeneca, is the lead author on her recently published paper in applied clinical trials, regarding the innovative approach of the EHR2EDC project, in which i~HD has been a partner. Nadir Ammour, also an i~HD founder from Sanofi, is also an author, along with our President Kalra, and collaborators from an innovative ICT company.